Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

New therapeutic options for metabolic-associated steatotic liver disease.

An increasing number of patients are being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including car...

T. Straatmijer, M. Mulder · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.